Search
for
Sort by
Research 481–510 of 1000+
- Alopecia areata
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Cepharanthine loaded nanoparticles coated with macrophage membranes for lung inflammation therapy
- Wnt is back in drugmakers' sights, but is it druggable?
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- Peptides in the Diagnosis and Treatment of Pancreatic Cancer and Other Pancreatic Diseases from Basic Research to Clinical Translation
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Pharmaceutical nanotechnology in Egypt: diverse applications and promising outcomes
- Can we teach old drugs new tricks?—Repurposing of neuropharmacological drugs for inflammatory skin diseases
- Advances in Chronic Wound Management: The Role of Antibiofilm-Based Wound Dressings and Theranostic Innovations
- In Vitro Evaluation of Topical Follicular Delivery of Minoxidil and Latanoprost Co-Entrapped in Lipid Nanocarriers
- An Update on Medical Treatment Options for Hidradenitis Suppurativa
- Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction
- Common pathologic pathways: A single prescription dream?
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- The Emerging Structural Pharmacology of ATP-Sensitive Potassium Channels
- Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa
- The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Oxygen, Metabolism, and Regeneration: Lessons from Mice
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic
- Repurposing of Linagliptin Similar FDA Approved Drugs as Antidiabetic Agents
- A Multifunctional MOF Heterojunction for Combating Antibiotic Resistance and Promoting Regenerative Immunity
- Nanotechnology in Cosmetics: An Overview
- Prioritizing susceptibility genes for the prognosis of male-pattern baldness with transcriptome-wide association study
- Advances in nucleoside monophosphate prodrugs as anti-HCV agents
- Docking and Molecular Dynamics Identify Leads against 5 Alpha Reductase 2 for Benign Prostate Hyperplasia Treatment
- Interventions for preventing the progression of autosomal dominant polycystic kidney disease
- Cationic nanoemulsions enable follicle-associated delivery with reduced systemic exposure for combined minoxidil/finasteride therapy against androgenetic alopecia